Daniel Friedman, MD

Assistant Professor of Medicine
Campus mail 2301 Erwin Road, Suite 7451, Durham, NC 27701
Phone (919) 681-6020
Email address daniel.friedman@duke.edu

My research areas of interest include improving the safety and efficacy of complex ablation and optimal use of pacemakers in patients with heart failure, including cardiac resynchronization therapy and conduction system pacing. I am also interested in non-pharmacologic management of atrial fibrillation, including catheter ablation and left atrial appendage occlusion, and understanding optimal use of novel and emerging technologies.

Education and Training

  • Board Certified, Clinical Cardiac Electrophysiology, American Board of Internal Medicine, 2020 - 2030
  • Fellowship, Clinical Cardiac Electrophysiology, Duke University School of Medicine, 2017 - 2019
  • Board Certified, Cardiovascular Diseases, American Board of Internal Medicine, 2016 - 2026
  • Board Certified, Internal Medicine, American Board of Internal Medicine, 2013 - 2023
  • Fellowship, Cardiovascular Diseases, Duke University School of Medicine, 2013 - 2017
  • Residency, Internal Medicine, Massachusetts General Hospital, 2011 - 2013
  • M.D., Cornell University, Weill Medical College, 2010
  • B.S., Cornell University, 2006
  • C., High School, 2002

Publications

Zeitler, Emily P., Daniel J. Friedman, James P. Daubert, Sana M. Al-Khatib, Scott D. Solomon, Yitschak Biton, Scott McNitt, Wojciech Zareba, Arthur J. Moss, and Valentina Kutyifa. “Reply: The Benefit of Cardiac Resynchronization Therapy Is Not Hindered by the Number of Comorbidities.” J Am Coll Cardiol 70, no. 16 (October 17, 2017): 2097–98. https://doi.org/10.1016/j.jacc.2017.07.795.

PMID
29025566
Full Text

Al-Khatib, S. M., D. J. Friedman, P. L. Hess, P. H. Pun, and G. D. Sanders. “Do Implantable Cardioverter-Defibrillators Lower the Risk of Sudden Death and Total Mortality in Patients with End-Stage Renal Disease?” Current Cardiovascular Risk Reports 11, no. 9 (September 1, 2017). https://doi.org/10.1007/s12170-017-0551-8.

Full Text

Friedman, Daniel J., Sana M. Al-Khatib, Emily P. Zeitler, JooYoon Han, Gust H. Bardy, Jeanne E. Poole, J Thomas Bigger, et al. “New York Heart Association class and the survival benefit from primary prevention implantable cardioverter defibrillators: A pooled analysis of 4 randomized controlled trials.” In Am Heart J, 191:21–29, 2017. https://doi.org/10.1016/j.ahj.2017.06.002.

PMID
28888266
Full Text

Hess, Paul L., Hussein R. Al-Khalidi, Daniel J. Friedman, Hillary Mulder, Anna Kucharska-Newton, Wayne R. Rosamond, Renato D. Lopes, et al. “The Metabolic Syndrome and Risk of Sudden Cardiac Death: The Atherosclerosis Risk in Communities Study.” J Am Heart Assoc 6, no. 8 (August 23, 2017). https://doi.org/10.1161/JAHA.117.006103.

PMID
28835363
Full Text

Friedman, Daniel J., and Tristram D. Bahnson. “Catheter ablation of para-Hisian atrial tachycardias: Is "earliest" still synonymous with "best"?” Heart Rhythm 14, no. 7 (July 2017): 1006–7. https://doi.org/10.1016/j.hrthm.2017.03.031.

PMID
28347834
Full Text

Zeitler, Emily P., Daniel J. Friedman, James P. Daubert, Sana M. Al-Khatib, Scott D. Solomon, Yitschak Biton, Scott McNitt, Wojciech Zareba, Arthur J. Moss, and Valentina Kutyifa. “Multiple Comorbidities and Response to Cardiac Resynchronization Therapy: MADIT-CRT Long-Term Follow-Up.” J Am Coll Cardiol 69, no. 19 (May 16, 2017): 2369–79. https://doi.org/10.1016/j.jacc.2017.03.531.

PMID
28494974
Full Text

Pun, Patrick H., Shubin Sheng, Gillian Sanders, Adam D. DeVore, Daniel Friedman, Gregg C. Fonarow, Paul A. Heidenreich, Clyde W. Yancy, Adrian F. Hernandez, and Sana M. Al-Khatib. “Prescription of Guideline-Recommended Implantable Cardioverter Defibrillator and Cardiac Resynchronization Therapy Among Patients Hospitalized With Heart Failure and Varying Degrees of Renal Function.” Am J Cardiol 119, no. 6 (March 15, 2017): 886–92. https://doi.org/10.1016/j.amjcard.2016.11.043.

PMID
28160975
Full Text

Friedman, Daniel J., Haikun Bao, Erica S. Spatz, Jeptha P. Curtis, James P. Daubert, and Sana M. Al-Khatib. “Association Between a Prolonged PR Interval and Outcomes of Cardiac Resynchronization Therapy: A Report From the National Cardiovascular Data Registry.” Circulation 134, no. 21 (November 22, 2016): 1617–28. https://doi.org/10.1161/CIRCULATIONAHA.116.022913.

PMID
27760795
Full Text

Friedman, Daniel J., Craig S. Parzynski, Paul D. Varosy, Jordan M. Prutkin, Kristen K. Patton, Ali Mithani, Andrea M. Russo, Jeptha P. Curtis, and Sana M. Al-Khatib. “Trends and In-Hospital Outcomes Associated With Adoption of the Subcutaneous Implantable Cardioverter Defibrillator in the United States.” Jama Cardiol 1, no. 8 (November 1, 2016): 900–911. https://doi.org/10.1001/jamacardio.2016.2782.

PMID
27603935
Full Text

Pages